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Purpose: In humans, primary open-angle glaucoma (POAG) is a complex genetic disorder and is the leading cause of
visual impairment. Although all relevant genes were not identified, a small subset of the condition is found to be caused
by mutations in the MYOC and CYP1B1 genes. Inherited glaucoma also occurs in several breeds of dogs including beagles.
Primary glaucoma in beagles is inherited as an autosomal recessive trait. The purpose of this study is to investigate the
role of the CYP1B1 gene in beagles with POAG.
Methods: For the purpose of genetic analysis, total RNAs from the spleen of the canines were isolated and CYP1B1 cDNA
was prepared. Genomic DNA from five affected, two carriers, and 13 randomly selected normal beagles with no sign of
glaucoma was amplified by the polymerase chain reaction (PCR) using four pairs of primers. The amplified products were
directly sequenced using BigDye terminator cycle sequencing.
Results: Genomic DNA analyses have identified a substitution polymorphism (109A→C) in the 5’-untranslated region
(UTR) as well as a missense mutation (P93R) in exon 2 of the gene. Three affected, two carriers, and nine normal dogs
are heterozygous while two affected and three normal dogs are homozygous for the missense mutation. One normal dog
did not show this alteration. Normal dogs also contain the substitution polymorphism in the 5’-UTR. Similar experiments
with exon 3 did not identify any additional mutation in the gene.
Conclusions: The above results suggest that CYP1B1 alterations in the coding and UTR are not the primary cause of
glaucoma in beagles by possible monogenic association. They may be classified as polymorphisms or they may modify
glaucoma phenotype.
Glaucoma  in  humans  is  a  complex,  genetically
heterogeneous condition and is the leading cause of blindness
worldwide. It is classified into primary open-angle (POAG),
primary  closed-angle  (PCAG)  and  primary  congenital
glaucoma (PCG). The disease is frequently associated with
elevated intraocular pressure (IOP) and involves defects in the
trabecular meshwork (TM) and the anterior chamber of the
eye,  leading  to  the  obstruction  of  aqueous  outflow,  IOP,
progressive  degeneration  of  the  optic  nerve  and  retinal
ganglion cell death causing blindness mostly in adults [1].
Mechanisms  independent  of  IOP  are  also  implicated  in
glaucomatous degeneration. Several family studies suggest
that  specific  genetic  defects  may  contribute  to  the
pathogenesis of POAG. Although details about the inheritance
of  the  disease  remain  unclear,  genetic  regions  that  are
influencing POAG have been identified in large population
based  studies.  Subsequent  studies  have  demonstrated  that
mutations in myocilin (MYOC) and optineurin (OPTN) genes
are  associated  with  POAG  in  various  populations  [2].
Mutations in MOYC and OPTN together account for less than
5% of all POAG cases. In addition, mutations in CYP1B1 – a
member of the cytochrome P450 superfamily enzymes – have
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been implicated in POAG and juvenile open-angle glaucoma
[3-5]. In children, PCG is an important cause of visual loss
and  is  diagnosed  during  the  neonatal  or  infantile  period
[6-8].  Inheritance  of  PCG  is  believed  to  be  autosomal
recessive  [9].  Recently,  three  PCG  loci  (2p21,  1p36,  and
14q24.3) have been mapped and a spectrum of mutations in
CYP1B1 (GLC 3A) have been implicated in the pathogenesis
of the disorder, suggesting that CYP1B1 is the major PCG
causing gene [10-15]. Mutations in CYP1B1 are associated
with wide range of phenotypes and the alteration of this gene
could impair the morphogenesis of the outflow angle because
it has been proposed that CYP1B1 participates in iridocorneal
angle development [16]. Therefore, it may play an important
role in the physiology and development of the eye. Recently
it has been suggested that it may be a potential modifier gene
in early onset glaucoma [17].
The biological basis of the disease is not fully understood.
Investigations  in  human  glaucoma  have  been  hampered
because of a lack of suitable inherited POAG animal models
of human disease with the exception of inherited glaucoma in
beagles.  The  condition  in  beagles  is  transmitted  as  an
autosomal recessive trait and appears when the animals are
nine to 18 months old [18]. The pathogenesis, clinical signs,
and pharmacological responses of the glaucoma in beagles
have been previously investigated and reported [18-20]. For
our knowledge, this model system has not been investigated
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2470at the genetic level. Therefore, it is of interest for us to conduct
genetic analysis on this only available beagle model of open-
angle glaucoma. Such studies may provide additional insight
about the mechanism of this disease and also complement the
human studies.
METHODS
Isolation of canine CYP1B1 cDNA: For the purpose of genetic
studies, canine CYP1B1 cDNA was isolated. Three normal
beagles  were  euthanized  with  an  intravenous  overdose  of
pentobarbital sodium (these procedures were approved by the
animal care and use committee of the graduate school of
agriculture and life sciences, University of Tokyo, Japan) and
small pieces of spleen tissues were excised. By using an RN
easy  mini-kit  (Qiagen,  Tokyo,  Japan)  total  RNAs  were
extracted  from  the  tissue.  From  this  total  RNAs,  single
stranded cDNA was synthesized with an oligo(dT)12-18 primer
and  the  SuperScript  III  reverse  transcriptase  (Invitrogen,
Tokyo, Japan). The extracted cDNA was stored at -20 °C. For
the  synthesis  of  the  second  strand  we  have  designed  the
oligonucleotide  primers  (Table  1)  using  the  sequence
information of the Canis familiaris chromosome 17 whole
genome  shotgun  sequence  (GenBank).  Amplification  was
carried  out  according  to  the  procedure  supplied  by  the
manufacturer using these primers (Table 1) and Phusion high
fidelity  DNA  polymerase  (Finnzymes,  Espoo,  Finland).
Briefly, polymerase chain reaction (PCR) amplification was
carried out in a thermocycler (Bio-Rad, Tokyo, Japan) and
consisted of an initial denaturation at 98 °C for 30 s, 35 cycles
of denaturation at 98 °C for 10 s, annealing at 73 °C for 30 s,
and extension at 72 °C for 45 s followed by a final extension
at 72 °C for 10 min. The PCR products were electrophoresed
on a 2% agarose gel and bands were visualized by ethidium
bromide staining. The amplified products were purified by
SUPREC-PCR (TaKaRa Bio Inc., Shiga, Japan) or Wizard
SV gel and PCR clean up system (Promega, WI).
DNA  sequencing  and  mutational  analysis:  The  purified
product was directly sequenced using a BigDye terminator v
1.1 cycle sequencing kit (Applied Biosystems, Foster city,
CA)  and  an  ABI  PRISM  3130-Avant  genetic  analyzer
(Applied  Biosystems).  This  sequence  information  was
deposited  in  GenBank  (Accession  #  FJ  824086.1).  The
sequence data were aligned and compared by using a genetic
information  processing  software  (GENETYX,  version
6.1.1.0,  Genetyx,  Tokyo,  Japan)  and  a  sequence  scanner
software  version  1.0  (Applied  Biosystems  2005).  For
mutational analyses, genomic DNA from peripheral blood
samples of normal and affected dog was extracted by using an
EZ1  –  DNA  blood  kit  and  the  BIOROBOT  EZ1  system
(Qiagen). Genomic DNA from normal and affected dogs was
amplified  and  subjected  to  sequence  analysis  as  detailed
above by using the same primers (except the nested primer)
listed in the Table 1. All three exons were amplified and both
strands were sequenced. Sequencing reactions were repeated
at least twice using freshly amplified DNA.
RESULTS
In order to understand the genetic basis of POAG in beagles,
we have previously shown that the condition is not associated
with MYOC [21]. As part of our continued interest in POAG,
in this report we have isolated canine CYP1B1 cDNA for
mutational  analysis.  The  gene  is  partially  characterized
(promoter region and splice sites are not characterized) and
contains three exons of which only exons two and three code
for the protein while the first exon contains a 5’-untranslated
region (UTR) of 354 base pairs. The putative open reading
frame begins in the second exon and the gene encodes a 543
amino acid protein. It is approximately 84% homologous to
the human gene at the levels of nucleotides and amino acids
(Figure  1).  For  the  purpose  of  genetic  analysis,  we  have
analyzed five affected, two carriers, and 13 randomly selected
normal beagles with no sign of glaucoma. The results are
summarized  in  Table  2.  Our  analyses  have  identified  a
substitution polymorphism (109A→C) in the 5’-UTR (Figure
2A-D, right-hand side) and it is present in affected, carrier and
normal  dogs  (Figre  2,  right-hand  side).  Additionally,  a
heterozygous missense mutation (P93R) in exon 2 of the gene
was identified in three affected and two carrier dogs (Figure
2C,D,  left-hand  side)  while  two  affected  dogs  are
homozygous (Figure 2B, left-hand side) for this mutation.
Among  normal  animals,  nine  of  thirteen  revealed
heterozygosity for the missense mutation (Figure 2A, left-
hand side), three of them are homozygous and one normal dog
did not contain this alteration. The missense mutation has
changed the encoded amino acid proline of the codon 93 to
arginine (P93R). Similar experiments with exon 3 did not
identify any additional mutation in the gene.
TABLE 1. PRIMERS USED IN CDNA ISOLATION AND MUTATIONAL ANALYSIS.
Region 5’–3’ Forward 5’–3’ Reverse
5’-UTR TCCCCTCTCACTGCCTACCA GGGATGGCGCGTTTTGACTC
Exon 2 CGCGATCTCAGGTTTGCGA TCATGAGCGCCGTGTGCTT
  TGCGGTTGAGCTGCTCGAA TCAAAGGCCCCAGCCCTATTACGGA
Nested AAGCACACGGCGCTCATGACGTT CACCTCGCAGGTCAGTCTGT
Exon 3 ACACGCATGAAGCACATC GACTTACGATAGGAAAGAGAGCA
In the table, UTR refers non-translated region (Exon 1).
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Glaucoma in beagles is inherited as an autosomal recessive
trait and the genetic basis of the disorder is not known. In this
report, we have isolated and analyzed canine CYP1B1 gene
(which is also mutated in human disorder) for mutations. Our
analyses have identified a substitution polymorphism in the
5’-UTR and a missense mutation in the exon 2 of the gene.
First  of  all,  because  normal  dogs  have  the  same  5’-UTR
substitution (heterozygote) and three of the thirteen normal
dogs  contain  the  same  missense  mutation  in  both  alleles
(frequency is about 24%) it is likely that these variations are
non-pathogenic. Secondly, these alterations did not segregate
with the disease. Hence it is also unlikely that it is pathogenic.
Figure  1.  A  comparative  analysis  of
amino  acid  sequence  between  human
and  canine  CYP1B1  genes.  Canine
CYP1B1 is 84% homologous to human
gene at the amino acid and nucleotide
level.  The  asterisk  indicates  identical
amino acids.




Mutational changes Genotype Polymorphic changes Genotype
1 normal P93P homozygote 109 A→C heterozygote
9 normal P93R heterozygote ND —
3 normal R93R homozygote ND —
3 affected P93R heterozygote 109 A→C heterozygote
2 affected R93R homozygote 109 A→C heterozygote
2 carriers P93R heterozygote 109 A→C heterozygote
The affected dogs have POAG. In the table, ND refers to not determined, P refers to proline (normal amino acid), and R refers
to arginine.
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mouse, rat and humans. It is surprising that its alteration to
arginine  did  not  produce  the  phenotype  in  homozygote
animals (proline is considered to be a helix-breaking residue).
Therefore, it is tempting to speculate that this mutation may
also not have any functional significance or the mutation is
hypomorphic similar to the other reported mutations [22]. It
is interesting that many (approximately 72%) normal dogs are
heterozygous  for  the  missense  mutation  in  the  canine
population and there are three classes of normal beagles (no
mutation, heterozygotes and homozygotes) at the CYP1B1
locus.  Whatever  the  real  explanation  for  these  observed
results, glaucoma in beagles does not appear to be a simple
recessive  trait  and  it  may  have  a  multifactorial  etiology.
Functional assays as well as mating experiments in the future
may clarify the physiological role (if any) of polymorphic
missense  and  substitution  mutations.  Meanwhile,
identification  of  a  putative  predisposing  gene  may
substantially improve our knowledge of the pathogenesis of
glaucoma in beagles.
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